Marijuana-induced myocarditis in a 24-year-old man
Abstract
Keywords
Full Text:
PDFReferences
World drug report 2021. Vienna: UN, Office on Drugs and Crime; 2021 [https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html available at 06/20/2022]
Suerken CK, Reboussin BA, Sutfin EL, Wagoner KG, Spangler J, Wolfson M. Prevalence of marijuana use at college entry and risk factors for initiation during freshman year. Addict Behav. 2014; 39(1):302-307. doi: 10.1016/j.addbeh.2013.10.018
Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014; 370(23):2219-2227. doi: 10.1056/NEJMra1402309
Amar MB. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006; 105(1-2):1-25. doi: 10.1016/j.jep.2006.02.001
McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction. 2008; 103(7):1100-1109. doi: 10.1111/j.1360-0443.2008.02230.x
Mach F, Montecucco F, Steffens S. Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br J Pharmacol. 2008; 153(2):290-298.
Kattoor A, Mehta J: Marijuana and coronary heart disease. American College of Cardiology [https://www.acc.org/latest-in-cardiology/articles/2016/09/22/08/58/marijuana-and-coronary-heart-disease available at 06/20/2022]
Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000; 343(19):1388-1398. doi: 10.1056/NEJM200011093431908
Fabre A, Sheppard MN. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart. 2006; 92(3):316-320. doi: 10.1136/hrt.2004.045518
Kariyanna PT, Jayarangaiah A, Singh N, et al. Marijuana induced myocarditis: a new entity of toxic myocarditis. Am J Med Case Rep. 2018; 6(9):169-172. doi: 10.12691/ajmcr-6-9-1
Leontiadis E, Morshuis M, Arusoglu L, Cobaugh D, Koerfer R, El-Banayosy A. Thoratec left ventricular assist device removal after toxic myocarditis. Ann Thorac Surg. 2008; 86(6):1982-1985. doi: 10.1016/j.athoracsur.2008.04.092
Rodríguez-Castro CE, Alkhateeb H, Elfar A, Saifuddin F, Abbas A, Siddiqui T. Recurrent myopericarditis as a complication of marijuana use. Am J Case Rep. 2014; 15:60-62. doi: 10.12659/AJCR.889808
Tournebize J, Gibaja V, Puskarczyk E, Popovic B, Kahn J-P. Myocarditis and cannabis: An unusual association. Toxicol Anal Clin. 2016; 28(3):236. doi: 10.1016/j.toxac.2016.05.005
Nappe TM, Hoyte CO. Pediatric death due to myocarditis after exposure to cannabis. Clin Pract Cases Emerg Med. 2017; 1(3):166-170. doi: 10.5811/cpcem.2017.1.33240
Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H. Pharmacology and toxicology of major constituents of marijuana—on the metabolic activation of cannabinoids and its mechanism. Toxin Rev. 2003; 22(4):577-589. doi: 10.1081/TXR-120026915
Franz CA, Frishman WH. Marijuana use and cardiovascular disease. Cardiol Rev. 2016; 24(4):158-162. doi: 10.1097/CRD.0000000000000103
Tso M, Kushneriuk DJ, Bree TL, Nosib SS. Incidental acute ST elevation due to cannabis-induced myocarditis after a mechanical fall. CJC Open. 2021; 3(10):1303-1306. doi: 10.1016/j.cjco.2021.05.008
Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006; 113(6):876-890. doi: 10.1161/CIRCULATIONAHA.105.584532
Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis: experimental and clinical correlates. Circulation. 1997; 95(1):163-168. PMID: 8994432.
Nishii M, Inomata T, Takehana H, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004; 44(6):1292-1297. doi: 10.1016/j.jacc.2004.01.055
DOI: http://dx.doi.org/10.22551/2022.35.0902.10206
Copyright (c) 2022 Toktam Alirezaei, Mohammad Kalateh Agha Mohammadi, Rana Irilouzadian, Hamidreza Zarinparsa
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975